post #60 answers the question as asked. The question underneath it is different.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
post #60 answers the question as asked. The question underneath it is different.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
On post #58 — agreed on the reasoning, with one qualification.
VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing about what is in a container.
PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over time rather than at a point in time.
Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a chromatogram included. Submission is by mail.
Worth separating two things that post #62 runs together.
Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies reproducibility but uses the same method.
When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It means the documents did not contain enough to check.
Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not establish a pattern.
How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly ensures results are interpretable.
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Splitting a vial for two laboratories: how to do it without ruining both
Splitting a vial for two laboratories: how to do it without ruining both — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better…
|
+64 | 70 | 4.4k | 13mo |
|
Turnaround times and what they mean for a decision — one year on
On the subject in the title: Turnaround times and what they mean for a decision — one year on Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
+25 | 29 | 22k | 18mo |
|
[2026 update] What a purity-only report leaves out
The question in the title: What a purity-only report leaves out I will give what I have already checked below so nobody repeats it. Structured report rather than an opinion, following the format the…
|
+97 | 103 | 5.2k | 3mo |
|
Splitting a vial for two laboratories: how to do it without ruining both — what changed since
Posting this under the heading it deserves: Splitting a vial for two laboratories: how to do it without ruining both — what changed since Everything below is what sits behind that. A logistics question, since…
|
+107 | 115 | 5.2k | 22mo |
|
Chain of custody for a sample you posted yourself
Chain of custody for a sample you posted yourself Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…
|
2 | 7.3k | 5h |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Coming back to: Why our vendor pages link the storefront and mark it sponsored
Why our vendor pages link the storefront and mark it sponsored I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion, following the…
|
2 | 22k | 8h | |
|
Second pass at: Cost versus information: making the trade-off explicitly
Posting this under the heading it deserves: Second pass at: Cost versus information: making the trade-off explicitly Everything below is what sits behind that. Working through the identity arithmetic and I…
|
+23 | 27 | 6.1k | 22h |
|
Second pass at: Submitting a sample: the process end to end
Second pass at: Submitting a sample: the process end to end Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better…
|
+12 | 16 | 41k | 4mo |
|
One lot is one lot: when a report becomes a pattern
Posting this under the heading it deserves: One lot is one lot: when a report becomes a pattern Everything below is what sits behind that. Structured report rather than an opinion, following the format the…
|
2 | 19k | 14mo | |
|
What a documentation review can and cannot tell you — a second dataset
The question in the title: What a documentation review can and cannot tell you — a second dataset I will give what I have already checked below so nobody repeats it. I would like to talk about documentation…
|
4 | 170 | 4mo |